Asia Pacific Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029

Asia Pacific Autoimmune Disease Diagnostics Market Size

According to Straits Research analysis, the Asia Pacific Autoimmune Disease Diagnostics Market was valued at USD 1310.08 Million in 2024 and is projected to reach USD 2087.35 Million by 2029, expanding at a CAGR of 9.9% during the forecast period. The market growth is predominantly driven by the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies. Moreover, the rising healthcare expenditures and efforts by key players to improve their services also boost the market growth. Technological advancements such as next-generation sequencing and high-throughput screening present significant opportunities for market expansion. Furthermore, increasing penetration of genomic sequencing in disease diagnostics and a growing emphasis on personalized medicine will bolster market expansion. The APAC region, with its strategic innovations and advancements in healthcare, is poised to become a significant contributor to the global autoimmune disease diagnostics market.